To differentiate the indication to treat the clinically isolated syndrome on the bases of different clinical onsets. The subgroup analyses from a Cochrane meta-analysis

To differentiate the indication to treat the clinically isolated syndrome on the bases of different clinical onsets. The subgroup analyses from a Cochrane meta-analysis

Bibliographic Details
Main Authors:	Clerico, M, Faggiano, F, Palace, J, Tintore, M, Durelli, L
Format:	Journal article
Published:	2009

Similar Items

The best indication to early treat the clinically isolated syndrome based on the clinical onset. A Cochrane analysis
by: Clerico, M, et al.
Published: (2009)

Early treatment to prevent conversion of clinically isolated syndrome to clinically defined multiple sclerosis: a Cochrane metanalysis
by: Clerico, M, et al.
Published: (2008)

Conversion from clinically isolated syndromes to multiple sclerosis: how could we prevent it? A Cochrane review of published trials
by: Clerico, M, et al.
Published: (2007)

Prevention of conversion of clinically isolated syndromes to clinically defined multiple sclerosis. Evidence from a Cochrane meta-analysis
by: Clerico, M, et al.
Published: (2008)

Recombinant interferon-beta efficacy in preventing conversion of clinically isolated syndromes to clinically defined multiple sclerosis: a Cochrane meta-analysis
by: Clerico, M, et al.
Published: (2006)

A Cochrane review on immunomodulatory treatments in clinically isolated syndromes at risk of converting to multiple sclerosis
by: Clerico, M, et al.
Published: (2006)

Immunomodulatory treatments for preventing conversion from clinically isolated syndromes to multiple sclerosis: a Cochrane review on their efficacy
by: Clerico, M, et al.
Published: (2007)

Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate
by: Clerico, M, et al.
Published: (2005)

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
by: Clerico, M, et al.
Published: (2008)

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
by: Clerico, M, et al.
Published: (2008)

International clinical trials day and the Cochrane Library.
by: Clarke, M
Published: (2011)

International Clinical Trials Day and The Cochrane Library.
by: Clarke, M
Published: (2011)

Exploring treatment by covariate interactions using subgroup analysis and meta-regression in cochrane reviews: a review of recent practice.
by: Sarah Donegan, et al.
Published: (2015-01-01)

The Cochrane Collaboration and the Cochrane Library.
by: Clarke, M
Published: (2007)

Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes
by: Julien Tanniou, et al.
Published: (2016-02-01)

From meta‐analysis to Cochrane reviews
by: Nicole Ebner, et al.
Published: (2018-06-01)

The normality assumption on between-study random effects was questionable in a considerable number of Cochrane meta-analyses
by: Ziyu Liu, et al.
Published: (2023-03-01)

Ketamine: a novel antidepressant with a fast onset of action? Commentary on... Cochrane Corner
by: Smith, K, et al.
Published: (2016)

Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19
by: Deblina Raychaudhuri, PhD, et al.
Published: (2022-12-01)

The Cochrane Collaboration.
by: Scholten, R, et al.
Published: (2005)

Non‐motor phenotypic subgroups in adult‐onset idiopathic, isolated, focal cervical dystonia
by: Megan E. Wadon, et al.
Published: (2021-08-01)

Misleading subgroup analyses in GISSI
by: Peto, R
Published: (1990)

Evidence for differences in patterns of temporal trends in meta-analyses of diagnostic accuracy studies in the Cochrane Database of Systematic Reviews
by: Murphy, J, et al.
Published: (2024)

Diagnostic Models Combining Clinical Information, Ultrasound and Biochemical Markers for Ovarian Cancer: Cochrane Systematic Review and Meta-Analysis
by: Clare F. Davenport, et al.
Published: (2022-07-01)

Cochrane reviews will be in Medline.
by: Clarke, M, et al.
Published: (1999)

A large-scale assessment of temporal trends in meta-analyses using systematic review reports from the Cochrane Library
by: Fanshawe, T, et al.
Published: (2017)

Cochrane cancer network
by: Williams, C, et al.
Published: (1995)

MRI criteria for MS in patients with clinically isolated syndromes.
by: Montalban, X, et al.
Published: (2010)

Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
by: Piccolo, L, et al.
Published: (2016)

Extracts from The Cochrane Library: Scopolamine (hyoscine) for preventing and treating motion sickness.
by: Burton, M, et al.
Published: (2010)

Controversies in inflammatory bowel disease: exploring clinical dilemmas using Cochrane Reviews
by: East, JE, et al.
Published: (2019)

Use of Cochrane reviews in nationally-developed clinical practice guidelines in Latin America
by: Luis Ignacio Garegnani, et al.
Published: (2020-09-01)

IMPACT OF NICORANDIL IN ANGINA: SUBGROUP ANALYSES
by: IONA Study Group
Published: (2010-08-01)

Treating lower limb muscle cramps: a Cochrane systematic review
by: Chuter Vivienne, et al.
Published: (2011-05-01)

Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.
by: Rothwell, P
Published: (2005)

The Cochrane Collaboration and systematic reviews.
by: Clarke, M
Published: (2007)

903 Identification of non-small cell lung cancer (NSCLC) patient subgroups with poor response to immunotherapy using subgroup-level meta-analyses
by: Kinisha Gala, et al.
Published: (2023-11-01)

Response from the Cochrane Collaboration
by: Clarke, M, et al.
Published: (2008)

In defense of randomized clinical trials in surgery: Let us not forget Archie Cochrane's legacy.
by: Catto, J, et al.
Published: (2017)

Revisiting the Cochrane Collaboration. Meeting the challenge of Archie Cochrane--and facing up to some new ones.
by: Clarke, M, et al.
Published: (2001)